Capital Fund Management S.A. Sangamo Therapeutics, Inc Transaction History

Capital Fund Management S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $172,000 - $229,270	-19,090 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $194,145 - $241,297	19,090 New	19,090 $228,000
Q2 2020 Aug 13, 2020	SELL	$6.21 - $11.83 $160,354 - $305,474	-25,822 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$5.05 - $8.85 $130,401 - $228,524	25,822 New	25,822 $164,000
Q2 2019 Aug 12, 2019	SELL	$8.75 - $13.03 $477,802 - $711,516	-54,606 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$7.72 - $12.81 $188,136 - $312,179	24,370 Added 80.6%	54,606 $521,000
Q4 2018 Feb 13, 2019	SELL	$9.51 - $16.6 $2.31 Million - $4.04 Million	-243,348 Reduced 88.95%	30,236 $347,000
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $3.57 Million - $5.21 Million	273,584 New	273,584 $4.64 Million

141

60.4M

1.46M

1.84M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $160M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.